The evolution of patient-focused drug development and Duchenne muscular dystrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The evolution of patient-focused drug development and Duchenne muscular dystrophy

Published:2020-01-02 Issue:1 Volume:20 Page:57-68
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Crossnohere Norah L.¹²^ORCID,Fischer Ryan³,Crossley Emily⁴,Vroom Elizabeth⁵,Bridges John FP¹²

Affiliation:

1. Department of Health, Behavior and Society, Johns Hopkins School of Public Health, Baltimore, MD, USA

2. Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, OH, USA

3. Parent Project Muscular Dystrophy, Hackensack, NJ, USA

4. Duchenne UK, London, UK

5. Duchenne Parent Project Muscular Dystrophys, Amsterdam, NL, Netherlands

Funder

Parent Project Muscular Dystrophy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1734454

Reference101 articles.

1. FDA mission. [cited 2020 Mar 2]. Available from: https://www.fda.gov/aboutfda/whatwedo/default.htm-mission.

2. The Political Economy Of FDA Drug Review: Processing, Politics, And Lessons For Policy

3. Benefit-Risk Assessments at the US Food and Drug Administration

4. From passengers to co-pilots: Patient roles expand

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. User experience with HIV molecular epidemiology in research, surveillance, and cluster detection and response: a needs assessment;Current Medical Research and Opinion;2024-09-09

2. Redefining Collaborative Dynamic in Drug Development: Patient Organizations as New Stakeholders for Oncology Clinical Trials in the U.S.;2024 Portland International Conference on Management of Engineering and Technology (PICMET);2024-08-04

3. Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU;Frontiers in Medicine;2024-05-23

4. Barriers to diverse clinical trial participation in Duchenne muscular dystrophy: Engaging Hispanic/Latina caregivers and health professionals;Orphanet Journal of Rare Diseases;2024-05-21

5. Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials;Hepatology Communications;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3